Singla Apresh, Broadbridge Vy, Mittinty Murthy, Beeke Carol, Maddern Guy J
University of Adelaide, Discipline of Surgery, Adelaide, South Australia, Australia.
Aust J Rural Health. 2014 Oct;22(5):249-56. doi: 10.1111/ajr.12133.
Previous Australian studies have suggested poorer survival of patients with colorectal cancer in remote areas. To date no studies have assessed the geographic disparity in patients with metastatic disease. This retrospective cohort study looks at geographic differences in the surgical care and survival of patients with metastatic colorectal disease. The paper utilises data from the South Australian Clinical Registry for Metastatic Colorectal Cancer (SACRMCC).
DESIGN, PARTICIPANTS, INTERVENTIONS AND MAIN OUTCOME MEASURES: Data on patients' socio-economic status, primary and metastatic tumour characteristics, treatment and survival was extracted from the SACRMCC database. A binomial model analysis was used to identify geographical differences in the surgical treatment of patients and a Cox proportional hazards model was used to identify any geographic differences in survival.
The findings showed no differences in the diagnosis of liver metastases or provision of liver surgery between geographic areas, however there was a reduced likelihood of liver surgery with increasing age. The median overall survival rate, from the date of diagnosis of metastatic disease, was 20.0 months and the distribution by geographic remoteness was 19.1 months, 20.2 months, 22.0 months and 20.4 months in Major Cities, Inner Regional, Outer Regional and Remote areas respectively. This was not statistically significant.
Overall, there was no evidence of a geographical disparity in the diagnosis, surgical treatment or survival in metastatic colorectal cancer. This may be due to the shift toward centralising surgical care in South Australia. Nevertheless, there remains a need to improve the uptake of surgical care in the growing elderly population.
此前澳大利亚的研究表明,偏远地区的结直肠癌患者生存率较低。迄今为止,尚无研究评估转移性疾病患者的地理差异。这项回顾性队列研究着眼于转移性结直肠癌患者手术治疗和生存情况的地理差异。本文利用了南澳大利亚转移性结直肠癌临床登记处(SACRMCC)的数据。
设计、参与者、干预措施及主要观察指标:从SACRMCC数据库中提取患者的社会经济状况、原发性和转移性肿瘤特征、治疗及生存数据。采用二项式模型分析确定患者手术治疗的地理差异,采用Cox比例风险模型确定生存方面的地理差异。
研究结果显示,不同地理区域在肝转移诊断或肝手术实施方面无差异,然而,肝手术的可能性会随着年龄增长而降低。从转移性疾病诊断之日起计算,总体中位生存率为20.0个月,按地理偏远程度分布,大城市、内区域、外区域和偏远地区的中位生存率分别为19.1个月、20.2个月、22.0个月和20.4个月。这在统计学上无显著差异。
总体而言,没有证据表明转移性结直肠癌在诊断、手术治疗或生存方面存在地理差异。这可能是由于南澳大利亚的手术治疗趋于集中化。尽管如此,在不断增长的老年人群中,仍有必要提高手术治疗的接受率。